期刊文献+

以冠心病为首发症状的糖尿病临床分析

下载PDF
导出
摘要 随着糖尿病发病率升高,其初发症状也不相同,现将我院1999年1月~2000年12月收治的以冠心病为首发症状的糖尿病103例进行临床分析与探讨.
作者 仇向丽
出处 《医学理论与实践》 2001年第12期1238-1239,共2页 The Journal of Medical Theory and Practice
  • 引文网络
  • 相关文献

参考文献3

二级参考文献20

  • 1[1]Goldberg RB. Risk factor modification for cardiac disease: cardiovascular disease in iabetic patients. Med Clin North Am, 2000,84(1)∶81-93.
  • 2[2]Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA,1999, 281(14)∶1291-1297.
  • 3[3]Marks JB, Raskin P. Cardiovascular risk in diabetes: a brief review. J Diabetes Complications, 2000,14(2)∶108-115.
  • 4[4]Rodriguez BL, Lau N, Burchfiel CM,et al. Glucose intolerance and 23-year risk of coronary heart disease and total mortality.The Honolulu Heart Program. Diabetes Care,1999,22(8)∶1262-1265.
  • 5[5]United Kingdom Prospective Diabetes Study (UKPDS) Group(1998). Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).Lancet,1998, 352(9131)∶837-853.
  • 6[6]Pyorala K, Pedersen TR, Kjekslaus J,et al.Scandinavian Simvistatin Survival Study (4S) Group. Cholesterol lowering with simvistatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvistatin Survival Study (4S). Diabetes Care,1997,20(4)∶614-620.
  • 7[7]Goldberg RB, Mellies MJ, Sacks FM,et al.CARE Investigators (1998). Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. Circulation,1998,98(23)∶2513-2519.
  • 8[8]Curb JD, Pressel SL,Camel GL,et al.Systolic Hypertension in the Elderly Program Cooperative Research Group.Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA,1996, 276(23)∶1886-1892.
  • 9[9]Staessen JA, Thijs L, Gasowski J,et al. Systolic Hypertension in Europe(Syst-Eur) Trial Investigators.Treatment of isolated systolic hypertension in the elderly: further evidence from the Systolic Hypertension in Europe (Syst-Eur) Trial. Am J Cardiol,1998, 82(9B)∶20R-22R.
  • 10[10]The Heart Outcomes Prevention Evaluation Study Investigators.Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med, 2000,342(3)∶145-153.

共引文献5

;
使用帮助 返回顶部